Skip to main content
Fig. 3 | BMC Complementary Medicine and Therapies

Fig. 3

From: Exploring the mechanism of the Fructus Mume and Rhizoma Coptidis herb pair intervention in Ulcerative Colitis from the perspective of inflammation and immunity based on systemic pharmacology

Fig. 3

Docking diagram of core active components and core targets of FM-RC in the treatment of UC. (a) The ligand-receptor interaction screening of quercetin and MAPK1. (b) The ligand-receptor interaction screening of Palmidin A and PIK3CA. (c) The ligand-receptor interaction screening of kaempferol and PIK3CA

Back to article page